Study Design
For this analysis, we included adult patients (18 years or older) who
underwent OHT within the aforementioned study period. Patients who
underwent concurrent simultaneous OHT with any other solid organ
transplants, as well as heterotopic heart transplants were excluded.
Patients were stratified based on donor-recipient sex pairing.
The primary outcome of this study was one-year posttransplant survival.
Secondary outcomes included postoperative complications, hospital length
of stay, and rates of drug-treated one-year acute rejection. Predictors
of one-year mortality were also modeled.